Mologic - BIG in tiny Science Revenue and Competitors

A global, rapid diagnostics company specialising in world-class lateral flow technology. \n\nMologic has capabilities and proven expertise to take products through all phases of product development, from concept to commercialization and can provide high value contract services to assist through the innovation and development phases, including manufacturing scale-up. \n\nDifficult technical problem solving, custom reagent development, recombinant protein expression, antibody production and custom production capability that incorporates low-mid volume manufacturing, are part of the offering that makes Mologic a unique end-to-end diagnostics service partner.\n\nOur diverse skills enable our scientists to be truly innovative, seeing solutions that other organizations may never even consider. \n\nMologic has a broad pipeline that spreads across multiple markets and disease states. The pipeline includes diagnostic products for Respiratory Disease (predicting and diagnosing exacerbations for COPD and Cystic Fibrosis), Sepsis (confirmation), Women’s Health (Bacterial Vaginosis, Thrush, Urinary Tract Infection), Infection/Infectious Disease (Dialysis, Dengue, Malaria). \n\nCE marked products include PERiPLEX® Peritoneal Dialysis Infection Diagnostic.\n\nMologic is seeking strategic partners for licensing and/or regional and global commercialisation of its products. \n\nFor more information, please email partners@mologic.co.uk